Teladoc (NYSE:TDOC) issued an update on its first quarter earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of -$0.43 to -$0.45 for the period, compared to the Thomson Reuters consensus estimate of ($0.38). The company issued revenue guidance of $86 million to $88 million, compared to the consensus revenue estimate of $83.76 million.Teladoc also updated its FY18 guidance to -$1.36 to -$1.41 EPS.
Shares of Teladoc (TDOC) traded up $1.85 on Wednesday, reaching $39.15. 655,531 shares of the company’s stock were exchanged, compared to its average volume of 1,143,119. The stock has a market cap of $2,260.00 and a price-to-earnings ratio of -27.17. The company has a debt-to-equity ratio of 0.83, a quick ratio of 5.08 and a current ratio of 5.08. Teladoc has a 1-year low of $19.60 and a 1-year high of $39.95.
TDOC has been the subject of a number of research reports. Canaccord Genuity boosted their target price on shares of Teladoc from $42.00 to $43.00 and gave the company a buy rating in a research note on Wednesday, January 31st. Oppenheimer boosted their target price on shares of Teladoc from $40.00 to $45.00 and gave the company an outperform rating in a research note on Tuesday, November 21st. SunTrust Banks reiterated a buy rating and set a $40.00 target price on shares of Teladoc in a research note on Friday, November 3rd. Chardan Capital reiterated a buy rating and set a $47.00 target price (down from $48.00) on shares of Teladoc in a research note on Wednesday. Finally, ValuEngine upgraded shares of Teladoc from a sell rating to a hold rating in a research note on Friday, February 2nd. One analyst has rated the stock with a sell rating, five have assigned a hold rating and twelve have issued a buy rating to the company’s stock. The stock presently has an average rating of Buy and an average target price of $40.14.
TRADEMARK VIOLATION WARNING: This story was first posted by Ticker Report and is the sole property of of Ticker Report. If you are reading this story on another site, it was stolen and reposted in violation of United States and international trademark & copyright law. The original version of this story can be viewed at https://www.tickerreport.com/banking-finance/3228098/teladoc-tdoc-releases-q1-earnings-guidance.html.
Teladoc, Inc is a telehealth company. The Company offers telehealth platform, delivering on-demand healthcare anytime, anywhere, through mobile devices, the Internet, video and phone. The Company’s solution connects its Members, with its over 3,000 board certified physicians and behavioral health professionals treating a range of conditions and cases from acute diagnoses, such as upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation.
Receive News & Ratings for Teladoc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc and related companies with MarketBeat.com's FREE daily email newsletter.